Evidence map›Paper›PMID 42807682›Full record

ArticleEJHaem2026

Felty Syndrome-Associated Clonal Cytotoxic T-Cell Disease With Terminal Aggressive Progression: Shared

Kei Saito, Akihiko Yokohama, Oh Kwan Ee, Momoka Sorimachi, Kenji Imamura, Nobuhiko Kobayashi, Yuri Miyazawa, Yoshiyuki Ogawa, Takayuki Saito, Takahiro Shirakura and 2 more

Abstract read
In one paragraph

Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kei SaitoDepartment of Hematology Gunma University Graduate School Medicine Meabashi Japan.ORCID https://orcid.org/0000-0001-6717-031X
Akihiko YokohamaDivision of Transfusion Service Gunma University Hospital Faculty of Medicine Gunma University Meabashi Japan.
Oh Kwan EeDepartment of Hematology Gunma University Graduate School Medicine Meabashi Japan.
Momoka SorimachiDepartment of Hematology Gunma University Graduate School Medicine Meabashi Japan.
Kenji ImamuraDepartment of Hematology Gunma University Graduate School Medicine Meabashi Japan.
Nobuhiko KobayashiDepartment of Hematology Gunma University Graduate School Medicine Meabashi Japan.
Yuri MiyazawaDepartment of Hematology Gunma University Graduate School Medicine Meabashi Japan.
Yoshiyuki OgawaDepartment of Hematology Gunma University Graduate School Medicine Meabashi Japan.
Takayuki SaitoDepartment of Laboratory Sciences Gunma University Graduate School of Health Sciences Meabashi Japan.
Takahiro ShirakuraClinical Department of Pathology Gunma University Hospital Maebashi Japan.
Sumihito NobusawaDepartment of Human Pathology Gunma University Graduate School of Medicine Meabashi Japan.
Hiroshi HandaDepartment of Hematology Gunma University Graduate School Medicine Meabashi Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Biological overlap between Felty syndrome (FS) and clonal cytotoxic T-cell disorders is increasingly recognized, but aggressive progression is uncommon. Methods: We investigated an autopsy-confirmed case of terminal aggressive clonal T-cell disease that developed after a 4-year clinical course diagnosed as FS using serial immunophenotypic and molecular analyses. Results: Evolving γδ T-cell populations, TCR clonality, shared Conclusion: This case provides clinicopathological evidence of long-term evolution in FS-associated clonal cytotoxic T-cell disease. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.

Indexed as

Felty syndromeSTAT3T‐cell large granular lymphocytic leukaemiaTET2γδ T‐cells

Identifiers

PMID42807682
PMCPMC13619063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.